Author:
Crowe J. Scott,Roberts Kevin J.,Carlton Timothy M.,Maggiore Luana,Cubitt Marion F.,Clare Simon,Harcourt Katherine,Reckless Jill,MacDonald Thomas T.,Ray Keith P.,Vossenkämper Anna,West Michael R.
Publisher
Springer Science and Business Media LLC
Reference32 articles.
1. Martini, E., Krug, S. M., Siegmund, B., Neurath, M. F. & Becker, C. Mend Your Fences: The Epithelial Barrier and its Relationship With Mucosal Immunity in Inflammatory Bowel Disease. Cmgh 4, 33–46 (2017).
2. Billmeier, U., Dieterich, W., Neurath, M. F. & Atreya, R. Molecular mechanism of action of anti-tumor necrosis factor antibodies in inflammatory bowel diseases. World J. Gastroenterol. 22, 9300–9313 (2016).
3. Randall, C. W. et al. From historical perspectives to modern therapy: a review of current and future biological treatments for Crohn’s disease. Therap. Adv. Gastroenterol. 8, 143–159 (2015).
4. Nielsen, O. H. & Ainsworth, M. A. Tumor Necrosis Factor Inhibitors for Inflammatory Bowel Disease. N. Engl. J. Med. 369, 754–762 (2013).
5. Worledge, K. L., Godiska, R., Barrett, T. A. & Kink, J. A. Oral administration of avian tumor necrosis factor antibodies effectively treats experimental colitis in rats. Dig. Dis. Sci. 45, 2298–2305 (2000).
Cited by
44 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献